Home / Treatments / Wegovy
Wegovy denials: what the review data shows
Independent reviewers have decided 606 published cases where an insurer denied Wegovy — and they overturned the insurer 88.6% of the time. A denial for Wegovy is a starting position, not a final answer.
Published decisions
606
2001–2026
Overturned
88.6%
537 denials reversed
By condition
Published outcomes when Wegovy was denied for these conditions.
| Condition | Decisions | Overturned |
|---|---|---|
| Obesity | 486 | 90.7% |
| Endocrine/metabolic | 18 | 66.7% |
| Diabetes Mellitus | 18 | 100% |
How to use this in your appeal
These are outcomes from California’s external review program — an independent physician panel that binds the insurer. Every state has an equivalent process, and internal appeals succeed even more often. Cite the outcome record for Wegovywhen you appeal: reviewers routinely find that denials like yours didn’t hold up.
SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · DERIVED AGGREGATE STATISTICS ONLY · METHODOLOGY
Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.